Acrivon Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $168 | 141 | 1.19 |
| 2025-03-31 | $14k | 7.1k | 2.03 |
| 2024-12-31 | $42k | 6.9k | 6.02 |
| 2024-09-30 | $38k | 5.4k | 7.00 |
| 2024-06-30 | $30k | 5.2k | 5.80 |
| 2024-03-31 | $31k | 4.3k | 7.15 |
| 2023-12-31 | $13k | 2.7k | 4.92 |
| 2023-09-30 | $21k | 2.2k | 9.56 |
| 2023-06-30 | $43k | 3.3k | 12.96 |